180 Life Sciences (ATNF) News Today $3.00 -0.43 (-12.54%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$2.92 -0.09 (-2.83%) As of 08/8/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ATNF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period 180 Life Sciences rises after raising $425 million for Ethereum strategyAugust 6 at 2:20 AM | au.investing.com180 Life Sciences Closes $425 Million Private Placement to Advance its Ethereum Treasury StrategyAugust 4, 2025 | prnewswire.com180 Life Sciences (NASDAQ:ATNF) Earns "Sell (E+)" Rating from Weiss RatingsJuly 31, 2025 | americanbankingnews.com180 Life Sciences Announce an Upsized $425 Million Private Placement to Establish an Ether Treasury Reserve Led by Consortium of Digital Asset Leaders to Launch ETHZillaJuly 29, 2025 | prnewswire.com180 Life Sciences Corp. (ATNF) Latest Press Releases - Seeking AlphaJuly 2, 2025 | seekingalpha.com180 Life Sciences Earnings Estimates, EPS & Revenue | NASDAQ:ATNF | BenzingaApril 21, 2025 | benzinga.com180 Life Sciences Corp. modifies former CEO's exit termsFebruary 8, 2025 | msn.com180 Life Sciences prices $2.9M registered direct offering at $2.41 per shareDecember 29, 2024 | markets.businessinsider.com180 Life Sciences CFO Omar Jimenez ResignsDecember 19, 2024 | markets.businessinsider.com180 Life Sciences files to sell 1.9M shares of common stock for holdersNovember 16, 2024 | markets.businessinsider.com180 Life Sciences files for secondary offering of common stockNovember 16, 2024 | msn.com180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform IntegrationOctober 31, 2024 | finance.yahoo.com180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of DirectorsOctober 30, 2024 | finance.yahoo.comElray Resources Announces Strategic Sale of Crypto iGaming TechnologyOctober 25, 2024 | markets.businessinsider.comSoaring $1-handle stocks leaping into IBKR’s most-active list may point to market frothOctober 23, 2024 | msn.com180 Life Sciences' Brave Decision To Switch to the iGaming IndustryOctober 18, 2024 | finance.yahoo.com180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial OfficerSeptember 12, 2024 | globenewswire.com180 Life Sciences Corp Ordinary SharesSeptember 3, 2024 | morningstar.comM180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral UptakeJuly 30, 2024 | globenewswire.com180 Life Sciences Granted an Additional Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing RequirementsJuly 23, 2024 | finance.yahoo.com180 Life Sciences Corp. (ATNFW)May 18, 2024 | finance.yahoo.com180 Life Sciences Corp.: 180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price RequirementMarch 14, 2024 | finanznachrichten.de180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price RequirementMarch 14, 2024 | finance.yahoo.com180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price RequirementMarch 14, 2024 | globenewswire.com180 Life Sciences (Nasdaq:ATNF) HeadlineTrading was temporarily halted for "ATNF" at 07:02 PM with a stated reason of "News pending."...February 28, 2024 | marketbeat.com180 Life Sciences Announces 1-For 19 Reverse Stock Split - Quick FactsFebruary 26, 2024 | markets.businessinsider.com180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance PlanFebruary 26, 2024 | globenewswire.com180 Life Sciences Corp.February 17, 2024 | thestreet.com180 Life Sciences Stock (NASDAQ:ATNF), Quotes and News SummaryDecember 20, 2023 | benzinga.com180 Life Sciences Hires Financial Adviser to Help Explore Strategic AlternativesDecember 4, 2023 | marketwatch.com180 Life Sciences Engages Financial Advisor to Explore Strategic AlternativesDecember 4, 2023 | finance.yahoo.com180 Life Sciences Corp.: 180 Life Sciences Announces Review of Strategic AlternativesNovember 28, 2023 | finanznachrichten.de180 Life Sciences Announces Review of Strategic AlternativesNovember 28, 2023 | finance.yahoo.com180 Life Sciences Corp. Common Stock (ATNF)October 7, 2023 | nasdaq.comInnovative Biotech Company Announces Agreement To Perform CBD Pill Clinical StudySeptember 15, 2023 | benzinga.com180 Life Sciences Corp. Announces Closing of $3 Million Public OfferingAugust 14, 2023 | finance.yahoo.com180 Life Sciences Teams Up With Hadassah Hospital To Test A New Formulation Of CBD For Enhanced Oral UptakeAugust 7, 2023 | benzinga.com180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral UptakeAugust 7, 2023 | finance.yahoo.com180 Life Sciences Provides Update on Regulatory Approval Process in the UK and US for Dupuytren’s Disease Treatment; Continues Consultations with the UK MHRA and Initiates a Type C Meeting Request With the US FDAAugust 3, 2023 | finance.yahoo.com180 Life Sciences Files A Provisional Patent For CBD-Based Appetite SuppressantJuly 31, 2023 | benzinga.com180 Life Sciences Corp. Announces the Filing of a Provisional Patent Describing the Combination of CBD With GLP-1 Agonists to Suppress AppetiteJuly 31, 2023 | finance.yahoo.com180 Life Sciences Corp. Announces Closing of $3 Million Registered Direct Offering and Concurrent Private PlacementApril 10, 2023 | finance.yahoo.com180 Life Sciences Corp. Announces $3 Million Registered Direct Offering and Concurrent Private PlacementApril 5, 2023 | finance.yahoo.com180 Life Sciences (Nasdaq:ATNF) HeadlineTrading was temporarily halted for "ATNF" at 01:04 PM with a stated reason of "LULD pause."...April 5, 2023 | marketbeat.comWhy Is 180 Life Sciences (ATNF) Stock Up 30% Today?April 5, 2023 | investorplace.com180 Life Sciences Announces Presentation at the Gordon ConferenceFebruary 28, 2023 | finance.yahoo.com180 Life Sciences Announces Presentation at the Gordon ConferenceFebruary 27, 2023 | finance.yahoo.com180 Life Sciences Announces Allowance of Claims for a US Patent for Dupuytren’s Disease Treatment and ApplicationFebruary 23, 2023 | finance.yahoo.com180 Life Sciences stock dips as recruitment in trial for Frozen shoulder closes amid challengesFebruary 23, 2023 | seekingalpha.com180 Life Sciences to get US patent linked to treating hand disorder DupuytrenFebruary 23, 2023 | seekingalpha.com Get 180 Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATNF and its competitors with MarketBeat's FREE daily newsletter. Email Address ATNF Media Mentions By Week ATNF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATNF News Sentiment▼0.000.38▲Average Medical News Sentiment ATNF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATNF Articles This Week▼20▲ATNF Articles Average Week Get 180 Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATNF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AVTX News Today VXRT News Today EXOZ News Today MGX News Today ELUT News Today BYSI News Today EPIX News Today ANRO News Today ABOS News Today IGMS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATNF) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 180 Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share 180 Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
